Diagenode

CRISPR/Cas9 antibodies

RNA-targeting CRISPR antibodies

The latest tool for CRISPR gene editing is a new CRISPR-C2C2 (Cas13a) system which utilizes RNA-guided RNA-targeting for RNA knockdown and binding in cells. C2C2 (Cas13a) may be useful for isolating specific RNA sequences or even studying single RNA molecules with high specificity. Unlike editing DNA as with Cas9 which makes permanent genomic changes,  targeting RNA with C2C2 allows temporarily altering the amount of protein potentially offering a better therapeutic approach in the future. 

Use Diagenode's new C2C2 (Cas13a) polyclonal antibody to determine precision and success metrics in CRISPR experiments.

Products

Cat. No.ProductApplicationPurity
C15310267-100 C2C2 Antibody
(100 μl)
WB Whole antiserum from rabbit containing 0.05% azide.
C15200249 C2C2 Antibody
(50 µg/50 µl)
WB Protein G purified monoclonal antibody
C15100149 LwaCas13a Antibody
(100 µl)
WB Concentrated cell culture supernatant.
C15200250 PspCas13b Antibody
(50 µg)
WB Protein G purified monoclonal antibody.

Events

  • IHEC Annual meeting 2022
    Quebec, Canada
    Oct 4-Oct 7, 2022
  • Danish RNA Society's 7th Annual Meeting on RNA
    Aarhus, Denmark
    Oct 11, 2022
  • ASHG 2022
    Los Angeles, California, USA
    Oct 25-Oct 29, 2022
  • International Conference on Epigenetics and Bioengineering 2022
    Houston, Texas, USA
    Oct 27-Oct 29, 2022
  • Long-Read Sequencing Meeting Uppsala LRUA22 Meeting
    Uppsala, Sweden
    Oct 31-Nov 2, 2022
  • Association for Molecular Pathology 2022
    Phoenix, Arizona, USA
    Nov 1-Nov 5, 2022
 See all events

News

 See all news


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics